CPHI Webinar Series

Exploring Technological Trends in the Future of Pharmaceutical Manufacturing

23rd May, 2024
4pm CET / 10am EST
What will this webinar address?

In the aftermath of COVID-19, the pharmaceutical industry finds itself presented with a chance to accelerate the adoption of technology-driven transformations in its operations. The use of AI, robotics, and 3D printing is experiencing a growing prevalence within drug manufacturing, with the surge attributed to the myriad advantages these technologies offer over traditional methods.

While there are promising advancements, there remains significant groundwork to cover before pharma can fully embrace the next stages of development. Challenges such as data security concerns, elevated costs, scarcity of skilled workforce, and maintaining the integrity of AI utilization, act as pivotal barriers that must be addressed for achieving more seamless integration. The question now is what steps is pharma taking to address these challenges and fully embrace Industry 4.0?

Join our CPHI webinar to hear from our technology experts on how to best use the latest tools and technologies the industry has to offer.

  • Reviewing current Robotic practices in manufacturing processes and how it can help improve the quality and consistency of drugs.
  • Highlighting 3D Printing’s role in producing drugs more efficiently and cost-effectively.

Stephanie Gaulding
CQA, CPGP, Executive Director, Regulatory Compliance
Pharmatech Associates, Inc. 

Ms. Gaulding serves as our Managing Director, bringing more than 25 years of experience in quality management systems and validation program management in Pharma, Biotech, Medical Device, and related life science industries. Drawing on her extensive background, Ms. Gaulding develops and delivers efficient and sustainable quality management systems assuring compliance with global regulatory requirements and industry best practices. 

William Whitford
Strategic Solutions Leader
Arcadis

Bill Whitford is the Life Science Strategic Solutions Leader for DPS Group Strategic Consulting Team, supporting innovative therapeutic developments and biomanufacturing processes. An invited lecturer at international conferences, Bill has published over 400 articles, book chapters and patents in the bioproduction arena and enjoys such appointments as serving on the BioProcessing International Editorial Advisory Board.  He has an h-index of 16 and an i10 index of 25.  An article of his recently brought the International Society of Pharmaceutical Engineers (ISPE) the 2022 APEX Award for Publication Excellence in the Technical & Technology Writing category for his article “AI’s Promise for ATMPs” published in the November-December 2021 issue of Pharmaceutical Engineering®.

This webinar is brought to you by

Overview
Exploring Technological Trends in the Future of Pharmaceutical Manufacturing
  • 23rd May, 2024
  • 4pm CET / 10am EST
  • 60 minutes
  • Free